Черника обыкновенная - фармакогнозия. Курсовая работа. Курсовая работа черника обыкновенная химический состав, фармакологическая активность, применение в клинике и препараты
 Скачать 1.08 Mb.
|
|
Ek S, Kartimo H, Mattila S, Tolonen A. Characterization of phenolic compounds from lingonberry (Vaccinium vitis-idaea). J Agric Food Chem 2006, 54(26):9834–9842 ESCOP Monographs 2nd ed. Myrtilli fructus – Bilberry fruit. European Scientific Cooperative on Phytotherapy, editor. Thieme, Stuttgart 2003, 345-350 Esselen M, Fritz J, Hutter M, Teller N, Baechler S, Boettler U, et al. Anthocyanin-rich extracts suppress the DNA-damaging effects of topoisomerase poisons in human colon cancer cells. Mol Nutr Food Res 2011, 55(Suppl 1):S143- 153 European Pharmacopoeia 8th ed. Bilberry fruit, dried - Myrtilli fructus siccus. Council of Europe. 01/2008:1588 European Pharmacopoeia 8th ed. Bilberry fruit, fresh - Myrtilli fructus recens. Council of Europe. 01/2008:1602 European Pharmacopoeia 8th ed. Bilberry fructus dry extract prepared from fresh bilberry fruit – Myrtilli fructus recentis extractum siccum raffinatum et normatum. Council of Europe. 07/2008:2394 Felgines C, Talavera S, Texier O, Gil-Izquierdo A, Lamaison JL, Remesy C. Blackberry Anthocyanins Are Mainly Recovered from Urine as Methylated and Glucuronidated Conjugates in Humans. J Agric Food Chem 2005, 53(20):7721-7727 Felgines C, Talavera S, Texier O, Besson C, Fogliano V, Lamaison JL, et al. Absorption and metabolism of red orange juice anthocyanins in rats. Br J Nutr 2006, 95(5):898-904 Felgines C, Texier O, Besson C, Vitaglione P, Lamaison JL, Fogliano V, et al. Influence of glucose on cyanidin 3-glucoside absorption in rats. Mol Nutr Food Res 2008, 52(8):959–964 Fleschhut J, Kratzer F, Rechkemmer G, Kulling SE. Stability and biotransformation of various dietary anthocyanins in vitro. Eur J Nutr 2006, 45(1):7- 18 155 Fossen T, Cabrita L, Andersen EM. Colour and stability of pure anthocyanins influenced by pH including the alkaline region. Food Chem 1998, 63:435-440 Friedrich H, Schönert J. Untersuchungen über einige Inhaltsstoffe der Blätter und Früchte von Vaccinium myrtillus. Planta Med 1973, 24:90-100 Frohne D. Heilpflanzenlexikon. Ein Leitfaden auf wissenschaftlicher Grundlage. Vaccinium myrtillus 8thed. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart 2006 [Polish Translation] Fuchikami H, Satoh H, Tsujimoto M, Ohdo S, Ohtani H, Sawada Y. Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos 2006, 34(4):577-582 Galvano F, Vitaglione P, Li Volti G, Di Giacomo C, Gazzolo D, Vanella L, et al. Protocatechuic acid: the missing human cyanidins' metabolite. Mol Nutr Food Res 2008, 52(3):386-387 Garcia V, Diban N, Gorri D, Keiski R, Urtiaga A, Ortiz I. Separation and concentration of bilberry impact aroma compound from dilute model solution by pervaporation. J Chem Technol Biotechnol 2008, 83:973–982 Gardner Z, McGuffin M. Botanical Safety Handbook. Vaccinium myrtillus L. American Herbal Products Association, CRC Press, Boca Raton (FL) 2013 Gatta L. Vaccinium myrtillus anthocyanosides in the treatment of venous stasis: controlled clinical study on sixty patients. Fitoterapia 1988, 59:19–26 Gloria E, Perla A. Effetto degli antocianosidi sulla soglia visiva assoluta. [Effect of anthocyanosides on the absolute visual threshold.] Ann Oftalmol Clin Ocul 1966, 92:595–607 Grismondi G. Contributo al trattamento delle flebopatie da stasi in gravidanza. [Treatment of pregnancy induced phlebopathies.] Minerva Gin 1981, 33:221-230 Gruenwald J, Brendler T, Jaenicke C, editors. PDR for Herbal Medicines. 4th ed. Medical Economics Co., Inc., Montvale 2000 Hansel R, Keller K, Rimpler H, Schneider G, editors. Hagers Handbuch der Pharmazeutischen Praxis. Drogen P-Z. Vol 6. Springer-Verlag, Berlin 1994 156 Heinonen M. Antioxidant activity and antimicrobial effect of berry phenolics- -a Finnish perspective. Mol Nutr Food Res 2007, 51:684-691 Hou DX, Yanagita T, Uto T, Masuzaki S, Fujii M. Anthocyanidins inhibit cyclooxygenase-2 expression in LPS-evoked macrophages: structure-activity relationship and molecular mechanisms involved. Biochem Pharmacol 2005, 70(3):417-25 Huttunen S, Toivanen M, Arkko S, Ruponen M, Tikkanen-Kaukanen C. Inhibition activity of wild berry juice fractions against Streptococcus pneumoniae binding to human bronchial cells. Phytother Res 2011, 25(1):122-127 Ichiyanagi T, Hatano Y, Matsugo S, Konishi T. Structural dependence of HPLC separation pattern of anthocyanins from Bilberry (Vaccinium myrtillus L.). Chem Pharm Bull 2004a, 52:628–630 Ichiyanagi T, Kashiwada Y, Ikeshiro Y, Hatano, Y Shida Y, Horie M, et al. Complete assignment of bilberry (Vaccinium myrtillus L.) anthocyanins separated by capillary zone electrophoresis. Chem Pharm Bull 2004b, 52(2):226–229 Jayle GE, Aubert L. Action des glucosides d’anthocyanes sur la vision scotopique et mésopique du sujet normal. Therapie 1964, 19:171–185 Johnson J, Maher P, Hanneken A. The flavonoid, eriodictyol, induces long- term protection in ARPE-19 cells through its effects on Nrf2 activation and phase 2 gene expression. Invest Ophthalmol Vis Sci 2009, 50(5):2398-2406 Kahle K, Kraus M, Scheppach W, Ackermann M, Ridder F, Richling E. Studies on apple and blueberry fruit constituents: Do the polyphenols reach the colon after ingestion? Mol Nutr Food Res 2006, 50(4-5):418–423 Kalt W, McDonald JE, Ricker RD,Lu X. Anthocyanin content and profile within and among blueberry species. Can J Plant Sci 1999, 79:617–623 Kalt W, Hanneken A, Milbury P, Tremblay F. Recent research on polyphenolics in vision and eye health. J Agric Food Chem 2010, 58(7):4001-4007 Karlsen A, Paur I, Bøhn SK, Sakhi AK, Borge GI, Serafini M, et al. Bilberry juice modulates plasma concentration of NF-kappaB related inflammatory markers in subjects at increased risk of CVD. Eur J Nutr 2010, 49(6):345-355 157 Katsube N, Iwashita K, Tsushida T, Yamaki K, Kobori M. Induction of apoptosis in cancer cells by Bilberry (Vaccinium myrtillus) and the anthocyanins. J Agric Food Chem 2003, 51(1):68-75 Kay CD. Aspects of anthocyanin absorption, metabolism and pharmacokinetics in humans. Nutr Res Rev 2006, 19(1):137–146 Kay CD, Mazza GJ, Holub BJ. Anthocyanins exist in the circulation primarily as metabolites in adult men. J Nutr 2005, 135(11):2582-2588 Kähkönen MP, Hopia AI, Heinonen M. Berry phenolics and their antioxidant activity. J Agric Food Chem 2001, 49(8):4076-4082 Kähkönen MP, Heinämäki J, Ollilainen V, Heinonen M. Berry anthocyanins: isolation, identification and antioxidant activities. J Sci Food Agric 2003, 83:1403- 1411 Kemperman RA, Bolca S, Roger LC, Vaughan EE. Novel approaches for analysing gut microbes and dietary polyphenols: challenges and opportunities. Microbiology 2010, 156:3224-3231 Keppler K, Humpf H-U. Metabolism of anthocyanins and their phenolic degradation products by the intestinal microflora. Bioorg Med Chem 2005, 13(17):5195-5205 Kim ES, Yu SY, Kwon SJ, Kwon OW, Kim SY, Kim TW, et al. Clinical Evaluation of Patients with non proliferative diabetic retinopathy following medication of anthocyanoside: Multicenter Study. Korean Ophthalmol Soc 2008, 49:1629-1633 Kolehmainen M, Mykkänen O, Kirjavainen PV, Leppänen T, Moilanen E, Adriaens M, et al-. Bilberries reduce low-grade inflammation in individuals with features of metabolic syndrome. Mol Nutr Food Res 2012, 56(10):1501-1510 Kong JM, Chia LS, Goh NK, Chia TF, Brouillard R. Analysis and biological activities of anthocyanins. Phytochemistry 2003, 64(5):923-933 Kramer JH. Anthocyanosides of Vaccinium myrtillus (Bilberry) for Night Vision—A Systematic Review of Placebo-controlled Trials. Surv Ophthalmol 2004, 49(6):618 158 Laaksonen O, Sandell M, Kallio H. Chemical factors contributing to orosensory profiles of bilberry (Vaccinium myrtillus) fractions. Eur Food Res Techn 2010, 231:271–285 Lamy S, Lafleur R, Bédard V, Moghrabi A, Barrette S, Gingras D, et al. Anthocyanidins inhibit migration of glioblastoma cells: structure-activity relationship and involvement of the plasminolytic system. J Cell Biochem 2007, 100(1):100-111 Laplaud PM, Lelubre A, Chapman MJ. Antioxidant action of Vaccinium myrtillus extract on human low density lipoproteins in vitro: initial observations. Fundam Clin Pharmacol 1997, 11(1):35-40 Lätti AK, Riihinen KR, Kainulainen PS. Analysis of anthocyanin variation in wild populations of bilberry (Vaccinium myrtillus L.) in Finland. J Agric Food Chem 2008, 56(1):190–196Levy Y, Glovinsky Y. The effect of anthocyanosides on night vision. Eye (Lond) 1998, 12:967-969 Lietti A, Forni G. Studies on Vaccinium myrtillus anthocyanosides. II. Aspects of anthocyanins pharmacokinetics in the rat. Arzneimittelforschung 1976, 26:832-835 Määttä-Riihinen KR, Kamal-Eldin A, Mattila PH, González-Paramás AM, Törrönen AR. Distribution and contents of phenolic compounds in eighteen Scandinavian berry species. J Agric Food Chem 2004, 52(14):4477-4486 Magnasco A, Zingirian M. Influenza degli antocianosidi sulla soglia retinica differnziale mesopica.[Influence of anthocyanosides on the mesopic differential threshold of the retina.] Ann Ottalmol Clin Ocul 1966, 92(3):188–193 Maher P, Hanneken A. Flavonoids Protect Retinal Ganglion Cells from Oxidative Stress–Induced Death. Invest Ophtalmo Vis Sci 2005, 46(12):4796-4803 Maher P, Hanneken A. Flavonoids protect retinal ganglion cells from ischemia in vitro. Exp Eye Res 2008, 86(2):366-374 Malaveille C, Hautefeuille A, Pignatelli B, Talaska G, Vineis P, Bartsch H. Dietary phenolics as antimutagens and inhibitors of tobacco-related DNA adduction in the urothelium of smokers. Carcinogenesis 1996(10), 17:2193-2200 159 Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005, 81(1 Suppl):230S242S Martín-Aragón S, Basabe B, Benedí JM, Villar AM. Antioxidant Action of Vaccinium myrtillus L. Phytother Res 1998, 12:104–106 Martín-Aragón S, Basabe B, Benedí JM, Villar AM. In vitro and in vivo Antioxidant Properties of Vaccinium myrtillus. Pharm Biol 1999, 37:109-113 Matsumoto H, Nakamura Y, Tachibanaki S, Kawamura S, Hirayama M. Stimulatory Effect of Cyanidin 3-Glycosides on the Regeneration of Rhodopsin. J Agric Food Chem 2003, 51(12):3560-3563 Matuschek MC, Hendriks WH, McGhie TK, Reynolds GW. The jejunum is the main site of absorption for anthocyanins in mice. J Nutr Biochem 2006, 17(1):31- 36 Mayser HM, Wilhelm H. Effects of anthocyanosides on contrast vision (abstract). Invest Ophthalmol Vis Sci 2001, 42(Suppl):63 Mazza G, Kay CD, Cottrell T, Holub BJ. Absorption of anthocyanins from blueberries and serum antioxidant status in human subjects. J Agric Food Chem 2002, 50(26):7731–7737 McGhie TK, Walton MC. The bioavailability and absorption of anthocyanins: towards a better understanding. Mol Nutr Food Res 2007, 51:702–713 Mian E, Curri SB, Lietti A, Bombardelli E. Anthocyanosides and the walls of the microvessels: further aspects of the mechanism of action of their protective effect in syndromes due to abnormal capillary fragility. Minerva Med 1977, 68(52):3565- 3581 Mills S, Bone K. Bilberry fruit (Vaccinium myrtillus). In: Principles and Practice of Phytotherapy. Churchill Livingstone, Edinburgh 2000 Morazzoni P, Bombardelli E. Vaccinium myrtillus L. Fitoterapia 1996, 67:3– 29 160 Morazzoni P, Magistretti MJ. Activity of Myrtocyan®, an anthocyanoside complex from Vaccinium myrtillus (VMA), on platelet aggregation and adhesiveness. Fitoterapia 1990, 61:13–21 Morazzoni P, Livio S, Scilingo A, Malandrino S. Vaccinium myrtillus anthocyanosides pharmacokinetics in rats. Arzneimittelforschung 1991, 41(2):128- 131Može S, Polak T, Gasperlin L, Koron D, Vanzo A, Poklar Ulrih N, et al. Phenolics in Slovenian bilberries (Vaccinium myrtillus L.) and blueberries (Vaccinium corymbosum L.). J Agric Food Chem 2011, 59(13):6998-7004 Muth ER, Laurent JM, Jasper P. The effect of bilberry nutritional supplementation on night visual acuity and contrast sensitivity. Altern Med Rev 2000, 5(2):164-173 Nielsen IL, Dragsted LO, Ravn-Haren G, Freese R, Rasmussen SE. Absorption and excretion of black currant anthocyanins in humans and Watanabe heritable hyperlipidemic rabbits. J Agric Food Chem 2003, 51(9):2813-2820 Nohynek LJ, Alakomi HL, Kähkönen MP, Heinonen M, Helander IM, Oksman-Caldentey KM, et al. Berry phenolics: antimicrobial properties and mechanisms of action against severe human pathogens. Nutr Cancer 2006, 54(1):18- 32 Nurmi T, Mursu J, Heinonen M, Nurmi A, Hiltunen R, Voutilainen S. Metabolism of berry anthocyanins to phenolic acids in humans. J Agric Food Chem 2009, 57(6):2274–2281 Ogawa K, Oyagi A, Tanaka J, Kobayashi S, Hara H. The protective effect and action mechanism of Vaccinium myrtillus L. on gastric ulcer in mice. Phytother Res 2011, 25(8):1160-1165 Paoletti A, Gallo E, Benemei S, Vietri M, Lapi F, Volpi R, et al. Interactions between Natural Health Products and Oral Anticoagulants: Spontaneous Reports in the Italian Surveillance System of Natural Health Products. Evid Based Complement Alternat Med 2011, 612150:1-5 161 Passamonti S, Vrhovsek U, Vanzo A, Mattivi F. The stomach as a site for anthocyanins absorption from food. FEBS Lett 2003, 544(1-3):210-213 Patras A, Brunton NP, O’Donnell C, Tiwari BK. Effects of thermal processing on anthocyanin stability in foods, mechanisms and kinetics of degradation. Trends Food Sci Techn 2010, 21:3-11 Pennarola R, Roco P, Matarazzo G, De Martino F, Mormile A, Labate L. L’azione terapeutica degli antocianosidi nelle alterazioni microcircolatorie da polinevrite da collanti. [The therapeutic action of the anthocyanosides in microcirculatory changes due to adhesive-induced polyneuritis.] Gazz Med Ital 1980, 139:485–491 Peris J, Pascual B, Garcia L, Muro N, Surra G, Vinuesa T. Drug herb interactions with oral anticoagulants. Pharm World Sci 2008, 30:677-678 Abstr. DI- 81, No 5. Published in: Reactions Weekly 2008, 1229:5 Perossini M, Chiellini S, Guidi G, Siravo D. Diabetic and hypertensive retinopathy therapy with Vaccinium myrtillus anthocyanosides (Tegens) double- blind placebo-controlled clinical trial. Ann Ottalmol Clin Ocul 1987, 113:1173-1190 Pourrat H, Bastide P, Dorier P, Tronche P. Préparation et activité thérapeutique de quelques glycosidesd'anthocyanes, Chim Thérap 1967, 2:33-38 Prior RL, Cao G, Martin A, Sofic E, McEwen J, O’Brien C, et al. Antioxidant capacity as influenced by total phenolic and anthocyanin content, maturity, and variety of Vaccinium species. J Agric Food Chem 1998, 46:2686-2693Prior RL, Cao G. Antioxidant Phytochemicals in Fruits and Vegetables: Diet and Health Implications. Hort Science 2000, 35(4):588-592 Pulliero G, Montin S, Bettini V, Martino R, Mogno C, Lo Castro G. Ex vivo study of the inhibitory effects of Vaccinium myrtillus anthocyanosides on human platelet aggregation. Fitoterapia 1989, 60:69–75 Puupponen-Pimiä R, Nohynek L, Alakomi HL, Oksman-Caldentey KM. Bioactive berry compounds – novel tools against human pathogens. Appl Microbiol Biotechnol 2005a, 67(1):8–18 162 Puupponen-Pimiä R, Nohynek L, Hartmann-Schmidlin S, Kähkönen M, Heinonen M, Maatta-Riihinen K, et al. Berry phenolics selectively inhibit the growth of intestinal pathogens. J Appl Microbiol 2005b, 98(4):991–1000 Puupponen-Pimiä R, Nohynek L, Alakomi HL, Oksman-Caldentey KM. The action of berry phenolics against human intestinal pathogens. Biofactors 2005c, 23(4):243-251 Rauha JP, Remes S, Heinonen M, Hopia A, Kähkönen M, Kujala T, et al. Antimicrobial effects of Finnish plant extracts containing flavonoids and other phenolic compounds. Int J Food Microbiol 2000, 56(1):3-12 Repossi P, Malagola R, De Cadilhac C. The role of anthocyanosides on vascular permeability in diabetic retinopathy. Ann Ottalmol Clin Ocul 1987, 113:357-361 Riihinen K, Ryynänen A, Toivanen M, Könönen E, Törrönen R, Tikkanen- Kaukanen C. Antiaggregation potential of berry fractions against pairs of Streptococcus mutans with Fusobacterium nucleatum or Actinomyces naeslundii .Phytother Res 2011, 25(1):81-87 Rivas-Gonzalo JC. Analysis of anthocyanins. In: Santos-Buelga C, Williamson G, editors. Methods in Polyphenol Analysis. The Royal Society of Chemistry, Cambridge 2003 Rotblatt M, Ziment I. Evidence-Based Herbal Medicine. Bilberry (Vaccinium myrtillus). In: Hanley and Belfus Inc, Philadelphia 2002 Sakakibara H, Ogawa T, Koyanagi A, Kobayashi S, Goda T, Kumazawa S, et al. Distribution and excretion of bilberry anthocyanins [corrected] in mice. J Agric Food Chem 2009, 57(17):7681-7686 Sala D, Rolando M, Rossi PL, Pissarello L. Effetto degli antocianosidi sulle “performances” visive alle basse luminanze. [Effect of anthocyanosides on visual performances at low illumination.] Minerva Oftalmol 1979, 21:283–285 Scharrer A, Ober M. [Anthocyanosides in the treatment of retinopathies.] Klin Monbl Augenheilkd 1981, 178(5):386–389 [German] 163 Schilcher H. Phytotherapie in der Kinderheilkunde. Wissenschaftliche Verlagsgesellschaft, Stuttgart 1992 [Polish Edition PZWL, Warszawa 1998] Schimmer O, Krüger A, Paulini H, Haefele F. An evaluation of 55 commercial plant extracts in the Ames mutagenicity test. Pharmazie 1994, 49(6):448-451 Selma MV, Espín JC, Tomás-Barberán FA. Interaction between phenolics and gut microbiota: role in human health. J Agric Food Chem 2009, 57(15):6485-6501 Shim SH, Kim JM, Choi CY, Kim CY, Park KH. Ginkgo biloba extract and bilberry anthocyanins improve visual function in patients with normal tension glaucoma. J Med Food 2012, 15(9):818-823 Slosse P, Hootelé C. Structure and absolute configuration of myrtine, a new quinolizidine alkaloid from Vaccinium Myrtillus. Tetrahedron Lett 1978, 4:397 |